Sign in

CIK 0001420565

  • Non-accelerated filer
  • Smaller reporting company

Rein Therapeutics, Inc.

Sign in to watch
Ticker
RNTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
134196017
Phone
+1 737-802-1989
Business address
12407 N. MOPAC EXPY., SUITE 250 #390, AUSTIN, TX, 78758
Former names
Aileron Therapeutics, Inc., AILERON THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-07-23 Musso Alan A Director Grant or award · Stock Option (right to buy) +17,500 17,500
2024-12-02 Musso Alan A Director Grant or award · Stock Option (right to buy) +35,000 35,000
2024-08-20 Musso Alan A Director Grant or award · Stock Option (right to buy) +2,725 2,725
2023-10-31 Musso Alan A Director Grant or award · Stock Option (right to buy) +5,450 5,450

Page 1 of 1 · 4 trades